Truist Adjusts Price Target on Elevance Health to $500 From $475

Truist has raised its price target on Elevance Health, Inc. (ticker: ELV) from $475 to $500 while maintaining a Buy rating on the stock. This adjustment is based on an updated valuation assessment of the company.